Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Aug;34(8):1463–1466. doi: 10.1128/aac.34.8.1463

Newer uses of intravenous immunoglobulins as anti-infective agents.

J E Pennington 1
PMCID: PMC171853  PMID: 2221853

Full text

PDF
1463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARANDUN S., KISTLER P., JEUNET F., ISLIKER H. Intravenous administration of human gamma-globulin. Vox Sang. 1962;7:157–174. doi: 10.1111/j.1423-0410.1962.tb03240.x. [DOI] [PubMed] [Google Scholar]
  2. Berkman S. A., Lee M. L., Gale R. P. Clinical uses of intravenous immunoglobulins. Ann Intern Med. 1990 Feb 15;112(4):278–292. doi: 10.7326/0003-4819-112-4-278. [DOI] [PubMed] [Google Scholar]
  3. Bernstein L. J., Ochs H. D., Wedgwood R. J., Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr. 1985 Sep;107(3):352–357. doi: 10.1016/s0022-3476(85)80505-9. [DOI] [PubMed] [Google Scholar]
  4. Björkander J., Cunningham-Rundles C., Lundin P., Olsson R., Söderström R., Hanson L. A. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med. 1988 Jan;84(1):107–111. doi: 10.1016/0002-9343(88)90016-2. [DOI] [PubMed] [Google Scholar]
  5. Calandra T., Glauser M. P., Schellekens J., Verhoef J. Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. J Infect Dis. 1988 Aug;158(2):312–319. doi: 10.1093/infdis/158.2.312. [DOI] [PubMed] [Google Scholar]
  6. Calvelli T. A., Rubinstein A. Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis. 1986 May-Jun;5(3 Suppl):S207–S210. [PubMed] [Google Scholar]
  7. Chirico G., Rondini G., Plebani A., Chiara A., Massa M., Ugazio A. G. Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J Pediatr. 1987 Mar;110(3):437–442. doi: 10.1016/s0022-3476(87)80514-0. [DOI] [PubMed] [Google Scholar]
  8. Cohn E. J., Oncley J. L., Strong L. E., Hughes W. L., Armstrong S. H. CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA. J Clin Invest. 1944 Jul;23(4):417–432. doi: 10.1172/JCI101508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Emanuel D., Cunningham I., Jules-Elysee K., Brochstein J. A., Kernan N. A., Laver J., Stover D., White D. A., Fels A., Polsky B. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med. 1988 Nov 15;109(10):777–782. doi: 10.7326/0003-4819-109-10-777. [DOI] [PubMed] [Google Scholar]
  10. Hague R. A., Yap P. L., Mok J. Y., Eden O. B., Coutts N. A., Watson J. G., Hargreaves F. D., Whitelaw J. M. Intravenous immunoglobulin in HIV infection: evidence for the efficacy of treatment. Arch Dis Child. 1989 Aug;64(8):1146–1150. doi: 10.1136/adc.64.8.1146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Haque K. N., Zaidi M. H., Haque S. K., Bahakim H., el-Hazmi M., el-Swailam M. Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants. Pediatr Infect Dis. 1986 Nov-Dec;5(6):622–625. doi: 10.1097/00006454-198611000-00004. [DOI] [PubMed] [Google Scholar]
  12. Krasinski K., Borkowsky W., Bonk S., Lawrence R., Chandwani S. Bacterial infections in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1988 May;7(5):323–328. doi: 10.1097/00006454-198805000-00006. [DOI] [PubMed] [Google Scholar]
  13. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  14. Lever A. M., Webster A. D., Brown D., Thomas H. C. Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet. 1984 Nov 10;2(8411):1062–1064. doi: 10.1016/s0140-6736(84)91506-x. [DOI] [PubMed] [Google Scholar]
  15. Mitra G., Wong M. F., Mozen M. M., McDougal J. S., Levy J. A. Elimination of infectious retroviruses during preparation of immunoglobulins. Transfusion. 1986 Jul-Aug;26(4):394–397. doi: 10.1046/j.1537-2995.1986.26486262753.x. [DOI] [PubMed] [Google Scholar]
  16. Noya F. J., Baker C. J. Intravenously administered immune globulin for premature infants: a time to wait. J Pediatr. 1989 Dec;115(6):969–971. doi: 10.1016/s0022-3476(89)80751-6. [DOI] [PubMed] [Google Scholar]
  17. Reed E. C., Bowden R. A., Dandliker P. S., Lilleby K. E., Meyers J. D. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med. 1988 Nov 15;109(10):783–788. doi: 10.7326/0003-4819-109-10-783. [DOI] [PubMed] [Google Scholar]
  18. Rousell R. H. Clinical safety of intravenous immune globulin and freedom from transmission of viral disease. J Hosp Infect. 1988 Aug;12 (Suppl 500):17–27. doi: 10.1016/0195-6701(88)90026-6. [DOI] [PubMed] [Google Scholar]
  19. Schaad U. B., Gianella-Borradori A., Perret B., Imbach P., Morell A. Intravenous immune globulin in symptomatic paediatric human immunodeficiency virus infection. Eur J Pediatr. 1988 Apr;147(3):300–303. doi: 10.1007/BF00442700. [DOI] [PubMed] [Google Scholar]
  20. Schmidt G. M., Kovacs A., Zaia J. A., Horak D. A., Blume K. G., Nademanee A. P., O'Donnell M. R., Snyder D. S., Forman S. J. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation. 1988 Dec;46(6):905–907. [PubMed] [Google Scholar]
  21. Schmidt R. E., Hartlapp J. H., Niese D., Illiger H. J., Stroehmann I. Reduction of infection frequency by intravenous gammaglobulins during intensive induction therapy for small cell carcinoma of the lung. Infection. 1984 May-Jun;12(3):167–170. doi: 10.1007/BF01640891. [DOI] [PubMed] [Google Scholar]
  22. Winston D. J., Ho W. G., Lin C. H., Bartoni K., Budinger M. D., Gale R. P., Champlin R. E. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med. 1987 Jan;106(1):12–18. doi: 10.7326/0003-4819-106-1-12. [DOI] [PubMed] [Google Scholar]
  23. Ziegler E. J., McCutchan J. A., Fierer J., Glauser M. P., Sadoff J. C., Douglas H., Braude A. I. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med. 1982 Nov 11;307(20):1225–1230. doi: 10.1056/NEJM198211113072001. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES